EUVIMEDEUVIMED entdecken
Crossref

CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US

Emily Harris

JAMA · 2024

DOI: 10.1001/jama.2024.11024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Doxycycline, Sexually Transmitted Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDoxycyclineSexually Transmitted DiseasesFemaleHumansMaleAntibiotic ProphylaxisCenters for Disease Control and Prevention, U.S.GonorrheaPractice Guidelines as TopicUnited StatesSexual and Gender MinoritiesTransgender Persons

Substanzen

Anti-Bacterial AgentsDoxycycline

Zitieren

APA

Harris, E. (2024). CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US. JAMA. https://doi.org/10.1001/jama.2024.11024

Vancouver

Harris E. CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US. JAMA. 2024. doi:10.1001/jama.2024.11024

BibTeX
@article{Harris2024,
  author = {Harris, Emily},
  title = {CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.11024}
}
Kostenlos starten →